Making CAR T-Cell Therapy Safer – The Scientist
|
Making CAR T-Cell Therapy Safer
The Scientist JCAR015 is not the first CAR T-cell therapy to have been associated with patient deaths. In fact, even those trials considered a success sometimes have troubling safety profiles. For example, Novartis’s lead candidate, the CD19-targeting CLT019, … |
Engadget |
A Japanese man just got another person’s stem cells transplanted in …
ScienceAlert In what’s reported to be a world-first, last Tuesday, a Japanese man received a pioneering retinal cell transplant grown from donor stem cells instead of his own. Man receives someone else’s reprogrammed stem cells – EngadgetEngadget Reprogrammed donor stem cells could be the remedy for any diseaseThe TechNews Stem Cell Research: Japanese Man’s Body Accepts Cells From …International Business Times |
Engadget |
A Japanese man just got another person’s stem cells transplanted in …
ScienceAlert In what’s reported to be a world-first, last Tuesday, a Japanese man received a pioneering retinal cell transplant grown from donor stem cells instead of his own. Man receives someone else’s reprogrammed stem cells – EngadgetEngadget Reprogrammed donor stem cells could be the remedy for any diseaseThe TechNews Stem Cell Research: Japanese Man’s Body Accepts Cells From …International Business Times |
|
The risks of unproven stem cell treatments
Radio New Zealand An expert in stem cell treatment is warning of dodgy operators in New Zealand offering unproven and potentially dangerous treatments. Auckland University Medical School lecturer Bronwen Connor’s warning comes after a recently-released scientific paper … |
Fusion |
We have now CRISPR‘d a human!
Fusion A group of Chinese scientists have become the first to use the game-changing gene-editing technology CRISPR-Cas9 on humans. Nature reported today that a team from Sichuan University inserted genetically modified cells into a patient with aggressive … CRISPR Gene-Editing Tested in a Person for the First TimeScientific American China Has Launched the First-Ever CRISPR Gene-Editing Trial in HumansFortune Human patient treated with CRISPR gene editing for the first timePopular Science MIT Technology Review –Gizmodo –IFLScience all 100 news articles » |
|
Patients’ immune system may influence effectiveness of cancer immunotherapy
Science Daily In blood samples taken prior to the start of immunotherapy, the researchers also found that patients with higher levels of circulating CD8, or cytotoxic, T cells — also known as killer T cells — and lower levels of regulatory T cells were associated … |